Concepedia
Statistics
Publications
3
Citations
115
H-Index
Active since
2001
Affiliations
Merck (United Kingdom)(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Tricia L. Johnson is an author at Merck (United Kingdom) specializing in drug discovery, pharmacotherapy, and medicine.
Top concepts
MedicinePharmacologyDrug DiscoveryPharmacotherapyImmunologyBiochemistryDrug ResistanceDrug DevelopmentMedicinal ChemistryMolecular Pharmacology
Publications per year
2001–2010
Quinazolines as cyclin dependent kinase inhibitors
Thais M. Sielecki, Tricia L. Johnson, Jie Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 85 citations · Full text
Medicinal Chemistry, Medicine, Mechanism Of Action +6
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor
Gregori J. Morriello, Gary G. Chicchi, Tricia L. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 19 citations · Full text
Nk1 Receptor, Molecular Pharmacology, Functional Selectivity +10
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists
Gregori J. Morriello, Sander G. Mills, Tricia L. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text
Pharmaceutical Science, Biochemistry, Medicine +6
1–3 of 3